marrow and serum ferritin, except possibly in patients with leukemia and metastatic tUmors to the bone marrow. The clinical value of the assay in relation to other indicators of iron status (i.e., hemoglobin, erythrocyte indices, serum iron and iron-binding capacity, and erythrocyte protoporphyrin) is in its specificity and sensitivity for assaying physiological iron stores.
Immunoradiometric analysis has facilitated the routine measurement of serum ferritin (1) . In normal subjects and in those with iron deficiency or iron overload the assay provides a useful and convenient method of assessing the status of iron stores (2) . Ferritin is the second most abundant iron-containing protein and is the major iron-storage protein in the body. Each molecule can accumulate up to about 4000 atoms of iron; when fully saturated, the complex contains more than 20% iron, by weight (i.e., >200 mg of iron per gram of ferritin).
Ferritin has been found in virtually every cell in which it has been sought, and is probably present in all plant and animal cells. Its synthesis seems to be induced by iron, indicating a common metabolic mechanism (3). Functionally, ferritin may represent an early evolutionary adaptation that permitted cells to immobilize excess iron, which is both ubiquitous and toxic in its ionic form. Though ferritin is mainly found intracellularly, trace amounts are present in serum. In recent years clinical interest in ferritin has stemmed from the observation that concentrations of this protein in the serum closelyparallel the body's reticuloendothelial iron stores and therefore may be a more accurate measure of iron storage than are the traditional determinations of serum iron or stainable iron in marrow (4).
Normally expected values for serum ferritin differ according to sex, except during childhood and old age, but fall within the range 10-250 tg/L. In iron deficiency the range is 0-10 g/L; in anemia not due to iron deficiency it is 75-2000 g/L; and in iron overload it may be as high as 5000-10 000 ig/L.
In this study, we report the correlation between serum ferritin and bone-marrow stainable iron, measured in 48 hospitalized patients. 
Materials and Methods
The principle of the two-site immunoradiometric assay of ferritin, originally introduced by Addison (1) , and further modified in the Ramco Kit (Fer-Iron; Ramco Labs., Inc., Houston, TX 77098),is a two-stage reaction. In the first stage, human serum ferritin is bound to a solid phase (plastic beads) and antihuman ferritin. In the second stage, antihuman ferritin radiolabeled with 125I is bound to the insoluble antihuman ferritin complex generated in the previous stage. The solid phase is then washed and counted in a gamma counter and the ferritin concentration is calculated by comparison with values on a standard curve. We evaluated bone-marrow iron on an 0 to 4+ scale from smears of bone-marrow aspirates stained with Prussian Blue.
In five cases in which smears were not available, bone biopsies were substituted.
All bone marrow evaluations were carried out without prior knowledge of the corresponding serum ferritin concentrations. However, we recognize and acknowledge the great subjectivity of the bone-marrow evaluation. Table 1 illustrates the mean concentration of ferritin in serum and the standard deviation in each of the marrow groups. The standard deviations are strikingly large and indicate considerable variation in each group. Individual values plotted on three-cycle semilog paper ( Figure 1) show that, in general, higher marrow iron contents are associated with higher serum ferritin values. The resulting scatter plot suggests a direct relationship. A least-squares regression line calculated for 41 of the plotted points had a correlation coefficient (numerical measure of the strength of the linear associations) of 0.6853. Great variations were noted in all the groups, but were most apparent in the group having no detectable marrow iron stores, where serum ferritin values ranged from 5-960 zgfL. This latter finding is most curious, because one should expect unusually low serum ferritin in such a case. Tables 2 and 3 list the admitting diagnosis for 21 of the 48 patients studied. Three patients (the first three listed in Table 2 ) with the lowest ferritin values had clear-cut iron deficiency. The others had various other pathological conditions. In several instances, increased serum ferritin values were associated with neoplasia. Values for five patients whose bone-marrow stores were evaluated by marrow section are also given in Table 2 . All but one of these patients had agnogenic myeloid metaplasia. Their serum ferritin ranged from 12 to 960 tg/L, and the corresponding bone marrow assays were negative for iron. It is not clear whether this clustering of results reflects the greater insensitivity of the iron stain on bone biopsy section or whether marrow iron is depleted in this condition. Table 3 illustrates results for eight patients whose serum ferritin values exceeded 400 ig/L. Again, there seems to be an association of increased serum ferritin values with neoplasia the patient has received (6). The serum ferritin concentration is also higher in inflammation (7), liver disease (8) , and several forms of cancer (9)-increases that may be related to accumulation of iron in tissues. In inflammatory disease, iron accumulates in the reticuloendothelial system as its release for hematopoiesis is impaired (10) . The changes in iron stores with liver disease are less well understood.
Results
Serum ferritin concentrations did show a correlation with marrow iron stores. Ferritin concentrations less than 15 gfL appeared to correlate with iron depletion. Conversely, increased marrow iron correlated strongly with increased serum ferritin. However, an increased ferritin concentration did not necessarily correlate with increased iron stores. It is well known that serum ferritin is increased in patients with inflainmatory conditions such as acute hepatitis and rheumatoid arthritis (9) or with malignancies such as acute leukemia and Hodgkin's disease (11) . Because of the widespread cellular distribution of the protein, above-normal serum ferritin can also be expected in conditions associated with tissue necrosis or increased cell turnover.
Thus, in the latter stages, the presence of normal or above-normal ferritin concentrations does not rule out iron deficiency. This discrepancy probably (Figure 1) , especially in those patients with no stainable marrow iron.
A diagnostic role for the serum ferritin assay is becoming apparent. It can provide information similar to that obtained by the invasive bone-marrow aspirate stained for iron (12) .
Of the two techniques, serum ferritin seems more routinely applicable because of the convenience of sampling. The assay requires 50 sL of serum, and quantitation of serum ferritin is considerably more objective and reproducible than is the assessment of bone-marrow iron. Serum ferritin also seems to be a more sensitive and specific index of declining iron stores than other measures of iron deficiency. In contrast to indices such as percentage transferrin saturation and quantitation of erythrocyte protoporphyrin, serum ferritin concentration becomes abnormal long before mobilizable iron stores are exhausted and before onset of clinically apparent anemia. Thus this assay is clinically valuable because of its sensitivity and convenience for assessing the status of physiological iron stores.
